Shares of Bellerophon Therapeutics, Inc. (BLPH) are rising more than 25% at $2.39.
The company today announced into a subscription agreement with a life sciences-focused institutional investor to sell 718,474 shares at a price of $2.00 per share and 1,781,526 prefunded warrants at $1.99 per pre-funded warrant.
The company intends to use the proceeds of about$5 million from this offering to complete its Phase 3 REBUILD study of inhaled nitric oxide (iNO) in patients at risk for pulmonary hypertension, and for working capital and general corporate purposes.
The offering is expected to close on March 7.
BLPH has traded in the range of $0.67-$3.50 in the last 1 year.
Source: Read Full Article
Lates News:
-
“Prepare”: This Crypto Analyst Says The Next Explosive Bitcoin Rally Is Right Around The Corner
-
Mysterious Anonymous Bitcoin Miner Rakes in $1.7 Million in $BTC Rewards in a Day
-
Bitcoin: A ‘Lottery Ticket’? Ireland’s Central Bank Governor Weighs In on Crypto
-
Earnings Scorecard Eclipses Recession Fears – Market Trends At This Hour
-
Bitcoin Primed for Gargantuan Rally Ahead Of 2024 Halving, Says Market Analyst